Discovery and evaluation of novel biomarkers reveal dasatinib as a potential treatment for a specific subtype of Triple-Negative Breast Cancer
Daniel Ortega-Álvarez, David Tébar-García, Marta Casado-Peláez, E Castillo-Agea, J Balibrea-Rull, David Olivares-Osuna, D Pérez-Parra, Cristina Guardia, Eva Musulén, Elena Vinuesa-Pitarch, Elsa Sánchez‐López, Fátima Postigo-Corrales, Ester Ballana, Anna Martínez‐Cardús, Mireia Margelí Vila, Manel Esteller, PL Fernández-Ruiz, Ginés Luengo‐Gil, Elisabetta Mereu, Eva María Galán‐Moya, Verónica Rodilla (2024). Discovery and evaluation of novel biomarkers reveal dasatinib as a potential treatment for a specific subtype of Triple-Negative Breast Cancer. , DOI: https://doi.org/10.1101/2024.07.24.603752.
